APA (7th ed.) Citation

Darenskaya, A. D., Medvedeva, B. M., & Rumyantsev, A. A. (2024). Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: Literature review and a case report. ABV-press.

Chicago Style (17th ed.) Citation

Darenskaya, A. D., B. M. Medvedeva, and A. A. Rumyantsev. Combination of Pembrolizumab and Lenvatinib in Second-line Therapy for MSS/pMMR Advanced Endometrial Cancer: Literature Review and a Case Report. ABV-press, 2024.

MLA (9th ed.) Citation

Darenskaya, A. D., et al. Combination of Pembrolizumab and Lenvatinib in Second-line Therapy for MSS/pMMR Advanced Endometrial Cancer: Literature Review and a Case Report. ABV-press, 2024.